BRANFORD, Conn.--(BUSINESS WIRE)--Aug. 26, 2024--
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 26th Annual H.C. Wainwright Global Investment Conference taking place in New York CitySeptember 9-11, 2024.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat on Tuesday, September 10th, at 4:00 PM ET.
A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20240826297214/en/
Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
